Updated hourlyHourly refreshTue, Oct 27, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
David Ferrera, CEO of RC Medical, explains how the venture studio turns physician ideas into standalone device companies, and why that structure fits interventional radiology better than a traditional consulting shop.
Oct 24 · 07:00·24-7 Press Release
Marketing & advertising
After 45 years in New City, the personal injury firm is changing how it reaches local residents while keeping its focus close to home.
Oct 24 · 07:00·24-7 Press Release
In the wire
Featuring festive colors, a Christmas-themed blade, playful accessories, and special-edition packaging, SnapFresh JingleCut combines cordless cutting functionality with a festive design for holiday crafting and gifting.
Oct 24 · 07:00·24-7 Press Release
In the wire
MUGGIÒ, Italy, 24th October 2026, FinanceWire … Read More
The post Tecnover Celebrates 41 Years of Italian Airless Spray-Painting Innovation appeared first on FinanceWire - Financial Press Release Distribution, Finance PR.
Oct 24 · 06:59·FinanceWire
Healthcare · Biotech & pharma
IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a favorable safety profile IMA402 achieved a cORR of 32%, 12.5 months median DOR and a 1-year OS rate of 91% in advanced melanoma patients with high PRAME expression Clinical profile of IMA402 reinforces development path across multiple solid tumor indications, including … Continue reading "Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting"
Oct 24 · 06:45·PressReach
Biotech & pharma · Government & policy
ZW191 demonstrates compelling anti-tumor activity in heavily pretreated patients with platinum-resistant ovarian cancer across folate receptor alpha (FRα) expression levels Confirmed objective response rates (cORR) of 64.5% at the 6.4 mg/kg dose in patients with high-grade serous platinum-resistant ovarian cancer Median duration of response not yet reached at either dose level at median 7 months … Continue reading "Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026"
Oct 24 · 06:45·PressReach
In the wire
ORION CORPORATION
PRESS RELEASE
24 OCTOBER 2026 at 9.35 EEST
Oct 24 · 06:35·GlobeNewswire
Finance · Real estate
New development marks the company’s entry into Pune’s high-velocity North-West growth cluster Birla Estates Pvt. Ltd., a wholly owned subsidiary of Aditya Birla Real Estate and part of the Aditya Birla Group, today announced a new development in Hinjewadi, undertaken through a Joint Development Agreement (JDA). The project carries a total revenue potential of approximately […]
Oct 24 · 06:34·Webnewswire
Automotive · Mining & metals
NEWMAN, Australia — October 16, 2026 — G Auto Electric & Air Con installs GPS tracking systems as part of its mine-spec vehicle fit-out work [read full press release...]
Oct 24 · 06:34·Express Press Release
Energy · Industrial
Solutions for residential, commercial and industrial applications advance the company’s focus on energy independence Solaryaan, a clean energy solutions brand of HowD Innovations Pvt. Ltd., is showcasing its comprehensive range of hybrid inverters and battery storage solutions at Renewable Energy India (REI) Expo 2026 from 22nd to 24th October 2026. The portfolio addresses residential, commercial […]
Oct 24 · 06:32·Webnewswire
Healthcare
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity observed across FRα expression levels Clinical activity with Sofe-M was maintained even in patients with prior PARP...
Oct 24 · 06:30·PR Newswire